The loss in FY20 is higher mainly because the money raised year through convertible notes is classified as an expense ($1.1 mil). Another cost that has gone up is the "Other Expenses" which makes up of IPO costs and development of Funch Baby products ($990K). All these costs are ONE OFF. If you strip these out this circa $2mil then overall, the position is pretty healthy. So FY21 - these costs wont be there and as management alluded to in the roadshow, they spent some money increasing capacity at the processing facility so they can now grow revenue to $10 mil without additional costs. Overall operating loss only $500-$600k Not $2.5 mil.
costs.
FFF Price at posting:
35.0¢ Sentiment: Buy Disclosure: Held
